Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. Key Points ...

The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large ...

Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...

A doctor from the University of Palermo in Italy has published a case study of an adult cocaine user who experienced reduced withdrawal symptoms when given GLP-1 therapy. In the case study published ...

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

These are some of the trends in weight management retailers and manufacturers are keeping an eye on in the new year to help ...

Kwame Raoul is among several state AGs raising the alarm following complaints about online teleheath company Hims & Hers ...

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter. The Fund performed roughly in line with the Benchmark, during a challenging ...